ASX:1AIPharmaceuticals, Biotechnology & Life SciencesBiotechnology
Algorae Pharmaceuticals Ltd
$0.011
Day Range
$0.000 – $0.000
52 Week Range
$0.000 – $0.024
Volume
0.00
Avg Volume (10D)
501.38K
Market Cap
$22.30M
Price Chart
Market Statistics
Open$0.011
Previous Close$0.011
Day High$0.000
Day Low$0.000
52 Week High$0.024
0Valuation
Market Cap22.30M
Shares Outstanding2.03B
Price to Book9.83
Trading Activity
Volume0.00
Value Traded0.00
Bid$0.012 × 41,666
Ask$0.013 × 1,143,121
Performance
1 Day-8.33%
5 Day-8.33%
13 Week-15.38%
52 Week120.00%
YTD-21.43%
Technical Indicators
RSI (14)40.81
50-Day SMA$0.012
200-Day SMA$0.014
Latest News
Biotechnology
Algorae Pharmaceuticals Expands AI Drug Combination Pipeline with Multi-Anchor AOS2 Program
Algorae expands AI drug-combo pipeline with AOS2: 18 anchors, 478k+ synergy predictions across cell lines; stock set for AI-driven discovery boost.
Biotechnology
Algorae Pharmaceuticals Enters Second Drug Synergy Screening Program with Peter MacCallum Cancer Centre
Algorae launches second AOS2 synergy program with Peter MacCallum Cancer Centre's VCFG; 24 drug combos across cancers; six-month preclinical data.
Biotechnology
Algorae Pharmaceuticals Partners with Cadila to Market Two New Medicines in Australia and NZ
Algorae inks Cadila deal to market two cardio/metabolic generics in Australia & NZ; Cadila develops/manufactures; AlgoraeRx handles regulatory and marketing.
Biotechnology
Algorae Pharmaceuticals Advances Commercial Pathway as AI Platform Validation and Distribution Agreements Gather Pace
Algorae Pharmaceuticals (ASX: 1AI) advances AlgoraeOS validation and signs Dr Reddy's distribution, signals near-term oncology revenue and stronger balance sheet.